Business context and reporting period
Natural Health Trends Corp. filed this Form 10-K for the fiscal year ended December 31, 2015. It sells NHT Global wellness, herbal, beauty, lifestyle and home products through direct-selling member networks and e-commerce. The filing is annual; it does not provide a clear standalone fourth-quarter financial result.
The business is highly concentrated in Hong Kong: 92.8% of 2015 net sales were reported there, and much of that revenue came from products delivered to members in China. The company reported 109,360 active members at year-end, up from 54,360.
Financial performance and liquidity
| Metric | 2015 | 2014 | Change |
|---|---|---|---|
| Net sales | $264.9 million | $124.6 million | +113% |
| Gross profit / margin | $210.8 million / 79.6% | $97.6 million / 78.3% | Margin +1.3 percentage points |
| Operating income / margin | $47.9 million / 18.1% | $20.8 million / 16.7% | Margin +1.4 percentage points |
| Net income | $47.2 million | $20.4 million | +132% |
| Diluted earnings per share | $3.82 | $1.61 | +137% |
| Cash provided by operations | $81.3 million | $30.6 million | +$50.7 million |
| Cash and cash equivalents at year-end | $104.9 million | $44.8 million | +$60.1 million |
Commissions were 47.8% of sales, versus 45.7% in 2014; selling, general and administrative costs were 13.6% of sales, versus 15.8%. The income tax provision was $552,000, compared with $266,000.
At year-end, current assets were $117.7 million and current liabilities $61.6 million, giving a 1.91 current ratio and $56.1 million of working capital. Total liabilities were $67.3 million. The filing does not report a debt balance. Cash included $57.5 million of available-for-sale investments classified as cash equivalents; $3.2 million was restricted cash, including a China consumer-protection deposit. A further $4.4 million of cash was held in Chinese banks subject to foreign-currency controls.
Operating cash flow benefited from higher sales and increases in accrued commissions, other accrued expenses, eWallet balances and long-term incentive liabilities. Accordingly, the cash-flow increase was not solely a result of earnings growth. The company used $16.1 million for share repurchases and paid $1.7 million in common dividends during 2015.
Material changes versus 2014
- Hong Kong sales rose 121% to $245.7 million. Sales outside Hong Kong increased 41% to approximately $19.1 million; CIS sales fell 63% to $1.1 million, reflecting regional political unrest and ruble devaluation.
- Gross margin improved, attributed to higher product margins and lower logistics and third-party service-provider costs. Commission expense increased as a share of sales because of member cash and other incentive programs.
- SG&A rose 83% to $36.0 million, principally due to employee and incentive costs, professional and director fees, facilities, and higher payment-processing charges.
- Inventory increased to $10.5 million from $3.8 million, while accrued commissions rose to $19.6 million from $8.9 million. Amounts held in eWallets increased to $16.4 million from $2.1 million.
- Common-stock repurchases totaled $16.1 million in cash during 2015. The board increased the repurchase authorization to $70 million in January 2016; the company reported $12.1 million of additional repurchases in February 2016.
Outlook, risks, contingencies and unusual items
The company provided no specific revenue or earnings guidance. Management said existing cash and operating cash flow should fund normal operations and commitments for the foreseeable future, and identified Greater China and markets where existing members can support recruitment and sales, including Southeast Asia, as investment priorities. It was pursuing a preliminary application for a China direct-selling license but could not predict whether or when it would obtain one or whether any resulting operations would be profitable. A $3.1 million China deposit had been funded for the required consumer-protection fund.
- China regulation and concentration: The Hong Kong business accounted for nearly 93% of sales, much of it connected to China. Chinese authorities scrutinize the sector; regulatory action, adverse interpretation of the company’s model, or new rules could interrupt operations, impose penalties or require business-model changes. Management described January 2016 government meetings and related reports as mischaracterized; it said officials indicated there was insufficient evidence to warrant an investigation at one meeting.
- Litigation: Two securities class-action complaints and a shareholder derivative complaint, filed in 2015, allege, among other matters, misleading statements about the legality of China operations; the derivative suit also alleges fiduciary-duty breaches and harm related to insider sales and repurchases. The cases were in early stages, and the company said it intended to defend them. Claimed damages were indeterminate.
- Products and suppliers: Three products—Premium Noni Juice, Essential Probiotics and Triotein—account for a significant portion of revenue and each had a single supplier. A February 2016 amendment to a supply agreement required average annual purchases of at least $9.4 million over three years to maintain worldwide exclusivity; a shortfall could trigger a defined cure payment.
- Other exposures: The company cited member attrition, competition, product and direct-selling regulation, foreign exchange, tax and transfer-pricing uncertainty, and dependence on third-party manufacturers and information systems. It did not maintain a comprehensive product-liability insurance program.
- Tax and capital returns: The company recorded a $9.3 million deferred tax liability related to foreign earnings no longer considered permanently reinvested, with a corresponding valuation-allowance release and no significant net effect on 2015 tax provision. It repatriated $18.4 million of foreign earnings during 2015, offset by U.S. net operating losses. A $0.05-per-share dividend declared in March 2016 was payable later that month.
The independent auditor gave an unqualified opinion on the financial statements and internal control over financial reporting; management and the auditor concluded controls were effective at December 31, 2015.
Most important facts for investors to verify
- Whether the exceptional sales and member growth are sustainable, especially given the Hong Kong/China concentration and the lack of standalone Q4 figures in the provided filing text.
- Current status and potential consequences of the China license application, regulatory scrutiny and the three lawsuits.
- Product-level revenue concentration, supplier continuity, and the $9.4 million annual-average purchase commitment and related cure-payment terms.
- How much operating cash flow is recurring versus driven by increased accrued liabilities and eWallet balances, and the availability of cash subject to foreign controls or restrictions.
- Execution and funding of the expanded $70 million repurchase program, its related-party participation, and the proposed 2016 equity plan, which reserved at least 2.5 million shares subject to shareholder approval.